文献速递肝病

IL-33/ST2通路调控中性粒细胞迁移并预测重症酒精性肝炎预后

IL-33/ST2 pathway regulates neutrophil migration and predicts outcome in patients with severe alcoholic hepatitis.
PubMed 文献 · J Hepatol · 2020-01-15

该研究检测重症酒精性肝炎(SAH)、酒精性肝硬化及健康对照者的血清和循环中性粒细胞,发现SAH中IL-33诱饵受体sST2升高、CXCR2表达降低、中性粒细胞迁移能力下降,且sST2水平与治疗应答、2个月生存、无感染生存及感染概率相关,IL-33可部分纠正上述缺陷。

要点

  • SAH患者sST2升高,与治疗应答、2个月生存及感染风险相关。
  • SAH中性粒细胞CXCR2表达和迁移能力下降,IL-33可部分恢复。
  • 激素应答者(Lille<0.45)中性粒细胞迁移及对IL-33反应更强。

核心结论

  • IL-33/ST2通路在SAH中缺陷并预测结局。
  • 该缺陷与中性粒细胞CXCR2表达降低和迁移能力下降相关,IL-33可部分纠正,尤其在激素应答者中。
  • 结果提示IL-33对SAH及其感染并发症有治疗潜力。

研究设计与样本

  • 收集SAH、酒精性肝硬化患者及健康对照的血清和循环中性粒细胞。
  • 检测基线及暴露于IL-33后的IL-33/ST2通路活性和CXCR2,并测定中性粒细胞迁移能力。

主要发现

  • sST2在SAH中较肝硬化和对照升高。
  • sST2水平与SAH治疗应答、2个月生存、无感染生存及感染概率相关。
  • 内毒素血症与sST2仅弱相关。
  • GRK2在SAH和肝硬化中性粒细胞中过表达,IL-33可使其降低。
  • SAH中性粒细胞CXCR2低于肝硬化和对照,IL-33部分恢复SAH和肝硬化中的CXCR2表达。

临床怎么用

  • sST2可能用于SAH结局和感染风险预测。
  • IL-33/ST2通路及中性粒细胞迁移缺陷是潜在治疗靶点,尤其激素应答者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Severe alcoholic hepatitis (SAH) is associated with a high risk of infection. The IL-33/ST2 pathway is involved in sepsis control but data regarding its role in alcohol-related liver disease (ALD) are lacking. We aimed to characterize the role of IL-33/ST2 in the polymorphonuclear neutrophils (PMNs) of patients with ALD and SAH. METHODS: Serum and circulating neutrophils were collected from patients with SAH, alcoholic cirrhosis and healthy controls. We quantified IL-33/ST2 pathway activity and CXCR2 at baseline and after exposure to IL-33. We also determined the migration capacity of PMNs. RESULTS: The decoy receptor of IL-33 (soluble ST2 [sST2]) was increased in SAH vs. cirrhosis and controls, demonstrating the defect in this pathway during ALD. The sST2 level was associated with response to treatment, 2-month survival, infection-free survival and probability of infection in SAH. Endotoxemia was weakly correlated with sST2. GRK2, a negative regulator of CXCR2, was overexpressed in PMNs of patients with SAH and cirrhosis and was decreased by IL-33. CXCR2 levels on PMNs were lower in SAH vs. cirrhosis and controls. Treatment with IL-33 partially restored CXCR2 expression in SAH and cirrhosis. PMN migration upon IL-8 was lower in patients with SAH and cirrhosis vs. controls. Treatment with IL-33 partially restored migration in those with SAH and cirrhosis. Interestingly, the migration capacity of PMNs and the response to IL-33 were enhanced in responders to corticosteroids (Lille <0.45) compared to non-responders. CONCLUSION: The IL33/ST2 pathway is defective in SAH and predicts outcome. This defect is associated with decreased CXCR2 expression on the surface of PMNs and lower migration capacity, which can be corrected by IL-33, especially in patients responding to steroids. These results suggest that IL-33 has therapeutic potential for SAH and its infectious complications. LAY SUMMARY: The neutrophils of patients with severe alcoholic hepatitis are associated with a defect in the IL-33/ST2 pathway. This defect is associated with lower migration capacities in neutrophils and a higher probability of getting infected. Administration of IL-33 to the neutrophils at least partly restores this defect and may be effective at reducing the risk of infection in patients with severe alcoholic hepatitis.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Artru F, Bou Saleh M, Maggiotto F, et al. IL-33/ST2 pathway regulates neutrophil migration and predicts outcome in patients with severe alcoholic hepatitis. J Hepatol. 2020. PMID: 31953139. doi:10.1016/j.jhep.2019.12.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。